Showing 1 - 6 results of 6 for search 'Marianne Coste‐Burel', query time: 0.02s
Refine Results
-
1
Efficacy of anti‐severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell tra... by Alice Garnier, Amandine Le Bourgeois, Thierry Guillaume, Pierre Peterlin, Maxime Jullien, Marianne Coste‐Burel, Marie C Béné, Patrice Chevallier
Published 2022-11-01
Article -
2
Strong SARS-CoV-2 T-Cell Responses after One or Two COVID-19 Vaccine Boosters in Allogeneic Hematopoietic Stem Cell Recipients by Béatrice Clémenceau, Amandine Le Bourgeois, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Maxime Jullien, Jocelyn Ollier, Audrey Grain, Marie C. Béné, Patrice Chevallier
Published 2022-09-01
Article -
3
SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine by Béatrice Clémenceau, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Maxime Jullien, Jocelyn Ollier, Audrey Grain, Marie C. Béné, Henri Vié, Patrice Chevallier
Published 2022-03-01
Article -
4
Anti‐SARS‐CoV‐2 vaccines in recipient and/or donor before allotransplant by Maxime Jullien, Marianne Coste‐Burel, Beatrice Clemenceau, Valentin Letailleur, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Berthe‐Marie Imbert, Jocelyn Ollier, Audrey Grain, Cyrille Touzeau, Philippe Moreau, Marie C Béné, Henri Vié, Patrice Chevallier
Published 2022-05-01
Article -
5
Safety and immunogenicity of a first dose of SARS‐CoV‐2 mRNA vaccine in allogeneic hematopoietic stem‐cells recipients by Patrice Chevallier, Marianne Coste‐Burel, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marie C. Béné, Berthe‐Marie Imbert, Thomas Drumel, Steven Le Gouill, Philippe Moreau, Beatrice Mahe, Viviane Dubruille, Nicolas Blin, Anne Lok, Cyrille Touzeau, Thomas Gastinne, Maxime Jullien, Sophie Vanthygem, Thierry Guillaume
Published 2021-08-01
Article -
6
The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics by Margaux Lelong, Régis Josien, Régis Josien, Marianne Coste-Burel, Marie Rimbert, Céline Bressollette-Bodin, Céline Bressollette-Bodin, Stéphane Nancey, Guillaume Bouguen, Matthieu Allez, Mélanie Serrero, Ludovic Caillo, Cléa Rouillon, Pierre Blanc, David Laharie, Raphaël Olivier, Laurent Peyrin-Biroulet, Nina Dib, Astrid De Maissin, Céline Montuclard, Caroline Trang-Poisson, Fabienne Vavasseur, Géraldine Gallot, Mathilde Berthome, Cécile Braudeau, Cécile Braudeau, Justine Chevreuil, Arnaud Bourreille, Catherine Le Berre
Published 2023-08-01
Article